BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/28/0.1/21.06.24 Stock

Warrant

W21NB

NLBNPFR1Y8V2

Market Closed - Euronext Paris 12:30:02 2024-06-04 pm EDT
0.155 EUR +14.81% Intraday chart for BNP PARIBAS ARBITRAGE/CALL/PFIZER INC/28/0.1/21.06.24
Current month+52.63%
1 month+93.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-04 0.145 +7.41%
24-06-03 0.135 +42.11%
24-05-31 0.095 +46.15%
24-05-30 0.065 0.00%
24-05-29 0.065 -23.53%

Real-time Euronext Paris

Last update June 04, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
W21NB
ISINNLBNPFR1Y8V2
Date issued 2024-02-07
Strike 28 $
Maturity 2024-06-21 (17 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.215
Lowest since issue 0.025
Delta0.7x
Omega 19.49
Premium1.29x
Gearing27.84x
Moneyness 1.024
Difference Strike -1.49 $
Difference Strike %-5.32%
Spread 0.03
Spread %27.27%
Theoretical value 0.1200
Implied Volatility 35.32 %
Total Loss Probability 38.48 %
Intrinsic value 0.0608
Present value 0.0592
Break even 29.30 €
Theta-0.02x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
29.49 USD
Average target price
31.92 USD
Spread / Average Target
+8.22%
Consensus
  1. Stock Market
  2. Warrants
  3. W21NB Warrant